Evidence map›Paper›PMID 36373229›Full record

ArticleMolecular omics2022

Deciphering

Nicholas M Riley, Carolyn R Bertozzi

Open access · greenFull text read
In one paragraph

Article in Molecular omics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 31 citations in OpenAlex.

  1. Discovery of a secretedGut microbes · 2026
    Article
  2. Deep Learning Prediction of O-Glycopeptide Tandem Mass Spectra Enhances O-Glycoproteomics.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  3. The protease cathepsin K can debulk the cancer glycocalyx.The Journal of biological chemistry · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Quantitative proteome-wide O-glycoproteomics analysis with FragPipe.Analytical and bioanalytical chemistry · 2025
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Nicholas M RileyDepartment of Chemistry, Sarafan ChEM-H, Stanford University, Stanford, California, USA. nmriley@stanford.edu.ORCID 0000-0002-1536-2966
Carolyn R BertozziDepartment of Chemistry, Sarafan ChEM-H, Stanford University, Stanford, California, USA. nmriley@stanford.edu.ORCID 0000-0003-4482-2754
Howard Hughes Medical Institute · USStanford Medicine · US

Funding

Investigating the Surface GlycoproteomeR01CA200423 · NCI · STANFORD UNIVERSITY · PI Carolyn Bertozzi · 2015 to 2026
$3.8M
Capturing the Holistic Glycocode through Systems GlycobiologyK99GM147304 · NIGMS · STANFORD UNIVERSITY · PI RILEY, NICHOLAS M · 2022 to 2022
$100k
Howard Hughes Medical InstituteNCI NIH HHS R01 CA200423NIGMS NIH HHS K99 GM147304
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

GlycopeptidesTandem Mass SpectrometryChromatography, LiquidGlycoproteinsMucinsOrganophosphorus CompoundsGlycopeptidesGlycoproteinsisopropyl methylphosphonic acidMucinsOrganophosphorus Compounds

Identifiers

PMID36373229
PMCPMC10010678
OpenAlexW4308955972

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read71
table measurements read2
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.